MedTrace Logo

Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients

NCT03389997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-04-19

No results posted yet for this study

Summary

The purpose of this study is to assess the duration of the viral shedding in hematology and oncology patients after a respiratory tract viral infection. This duration has not been much studied in that population whereas it is probably longer than that in immunocompetent patients. Thereby it may be a source of transmission amongst these immunocompromised patients.

Conditions

  • Respiratory Tract Viral Infection

Interventions

DIAGNOSTIC_TEST

nasal swabs

Iterative nasal swabs will be performed to screen for virus shedding

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • France CAZENAVE-ROBLOT, MD,PhD · CHU of POITIERS

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-07
Primary Completion
2024-02-15
Completion
2024-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03389997 on ClinicalTrials.gov